IE 11 is a very old Browser and it`s not supported on this site
de en
Interim report as at 30.06.2025
de en
Business reportPerformance / Multi-year comparison

Performance/Multi-year comparison

Indexed performance since launch

BB Biotech AG (SIX)-CHF


Rolling performance

SHARE

NAV

NBI TR

30.06.2024 – 30.06.2025

(20.4%)

(18.7%)

(17.1%)

30.06.2023 – 30.06.2024

7.2%

10.2%

12.9%

30.06.2022 – 30.06.2023

(27.1%)

(3.5%)

2.8%

30.06.2021 – 30.06.2022

(31.2%)

(32.4%)

(24.3%)

30.06.2020 – 30.06.2021

30.9%

17.0%

17.8%

Annual performance

SHARE

NAV

NBI TR

2024

(13.5%)

3.0%

7.6%

2023

(18.1%)

(7.4%)

(4.8%)

2022

(24.3%)

(11.0%)

(9.1%)

2021

8.3%

(11.5%)

3.0%

2020

19.3%

24.3%

15.8%

Cumulated performance

30.06.2025

SHARE

NAV

NBI TR

YTD

(9.8%)

(15.3%)

(13.8%)

1 year

(20.4%)

(18.7%)

(17.1%)

3 years

(37.8%)

(13.6%)

(3.8%)

5 years

(43.9%)

(31.6%)

(14.2%)

10 years

(8.8%)

(18.0%)

(1.0%)

since inception 1)

1 444%

1 609%

1 101%

1 09.11.1993

Annualized performance

30.06.2025

SHARE

NAV

NBI TR

1 year

(20.4%)

(18.7%)

(17.1%)

3 years

(14.6%)

(4.8%)

(1.3%)

5 years

(10.9%)

(7.3%)

(3.0%)

10 years

(0.9%)

(2.0%)

(0.1%)

since inception 1)

9.0%

9.4%

8.2%

1 09.11.1993

BB BIOTECH AG (XETRA)-EUR


Rolling performance

SHARE

NAV

NBI TR

30.06.2024 – 30.06.2025

(18.6%)

(16.3%)

(14.6%)

30.06.2023 – 30.06.2024

8.6%

11.9%

14.5%

30.06.2022 – 30.06.2023

(25.9%)

(1.2%)

5.2%

30.06.2021 – 30.06.2022

(23.9%)

(25.9%)

(17.0%)

30.06.2020 – 30.06.2021

26.5%

13.5%

14.4%

Annual performance

SHARE

NAV

NBI TR

2024

(14.1%)

1.7%

6.3%

2023

(15.2%)

(1.3%)

1.3%

2022

(19.0%)

(6.7%)

(4.5%)

2021

13.3%

(7.8%)

7.4%

2020

18.1%

24.8%

16.1%

Cumulated performance

30.06.2025

SHARE

NAV

NBI TR

YTD

(9.6%)

(14.8%)

(13.3%)

1 year

(18.6%)

(16.3%)

(14.6%)

3 years

(34.5%)

(7.5%)

3.0%

5 years

(36.9%)

(22.2%)

(2.2%)

10 years

0.8%

(8.7%)

10.5%

since inception 1)

1 317%

1 487%

1 252%

1 10.12.1997

Annualized performance

30.06.2025

SHARE

NAV

NBI TR

1 year

(18.6%)

(16.3%)

(14.6%)

3 years

(13.1%)

(2.6%)

1.0%

5 years

(8.8%)

(4.9%)

(0.5%)

10 years

0.1%

(0.9%)

1.0%

since inception 1)

10.1%

10.5%

9.9%

1 10.12.1997

Multi-year comparison

30.06.2025

2024

2023

2022

2021

Market capitalization at the end of the period (in CHF mn)

1 673.1

1 961.2

2 368.4

3 058.1

4 274.1

highchart-toggle

Net Asset Value at the end of the period (in CHF mn)

1 842.5

2 286.3

2 323.2

2 686.1

3 283.5

highchart-toggle

Number of shares (in mn)

55.4

55.4

55.4

55.4

55.4

highchart-toggle

Trading volume (in CHF mn)

486.5

974.0

906.3

1 482.0

2 101.0

highchart-toggle

Profit/(loss) (in CHF mn)

(341.2)

75.9

(206.6)

(357.8)

(404.8)

highchart-toggle

Closing price at the end of the period in CHF

30.20

35.40

42.75

55.20

77.15

highchart-toggle

Closing price at the end of the period in EUR

32.05

37.45

45.50

56.70

74.05

highchart-toggle

Stock performance (incl. distributions) 1)

(9.8%)

(13.5%)

(18.1%)

(24.3%)

8.3%

highchart-toggle

High/low share price in CHF

40.65/25.25

49.35/35.30

60.70/35.60

78.15/51.00

92.20/73.40

highchart-toggle

High/low share price in EUR

43.00/27.15

52.00/37.45

60.50/37.10

75.40/49.60

86.20/67.80

highchart-toggle

Premium/(discount) (annual average)

(12.7%)

(6.6%)

7.5%

20.5%

19.5%

highchart-toggle

Dividend in CHF

N.A.

1.80

2.00

2.85

3.85

highchart-toggle

Degree of investment (quarterly figures)

97.8%

111.3%

113.7%

112.8%

108.6%

highchart-toggle

Total Expense Ratio (TER) p.a. 2)

1.39%

1.33%

1.34%

1.27%

1.22%

highchart-toggle

1All figures in CHF %, total return-methodology

2Based on market capitalization